Dr. Salit is a professor of medicine at the University of Toronto and the director of the Immunodeficiency (HIV) Clinic at the Toronto General Hospital. He is also a staff physician in the Division of Infectious Diseases at the University Health Network and Mount Sinai Hospital, and a member of the University of Toronto Institute of Medical Sciences.
He earned his bachelor’s degree in zoology and medical degree from McGill University and completed a residency in medicine and a fellowship in infectious diseases at the Royal Victoria Hospital in Montreal. He was also a postdoctoral research fellow at The Rockefeller University in New York.
One of his current research focuses is anal cancer in HIV, which he is pursuing in CTN 292: HPV-SAVE. He is a principal investigator for this study, which is aiming to come up with an effective method for determining which HIV-positive men who have sex with men should be given a high-resolution anoscopy to check for abnormal changes in the anal tissues.
Other research interests include therapeutic and observational studies in HIV/AIDS and international health, with a focus on mother-to-child transmissions of HIV, enhancing adherence in taking antiretroviral therapy, and migrant workers and sexually transmitted infections.
Dr. Salit contributed to a CTN research publication discussing the Ontario HIV Treatment Network Cohort Study, whose aim is to develop and sustain a unique prospective research database governed by people living with HIV and used to support research that aims to improve the health and well-being of people living with HIV.
